These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10534163)

  • 41. BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features.
    Proietti A; Giannini R; Ugolini C; Miccoli M; Fontanini G; Di Coscio G; Romani R; Berti P; Miccoli P; Basolo F
    Thyroid; 2010 Nov; 20(11):1263-70. PubMed ID: 20950194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HBME-1 and CD15 immunocytochemistry in the follicular variant of thyroid papillary carcinoma.
    Ohta M; Ookoshi T; Naiki H; Imamura Y
    Pathol Int; 2015 Mar; 65(3):119-25. PubMed ID: 25597783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis.
    Galgano MT; Mills SE; Stelow EB
    Am J Surg Pathol; 2006 Oct; 30(10):1269-73. PubMed ID: 17001158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry].
    Guyétant S; Michalak S; Valo I; Saint-André JP
    Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY; Lin JD; Chou SC; Chao TC; Hsueh C
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD56, CD57, HBME1, CK19, Galectin-3 and p63 immunohistochemical stains in differentiating diagnosis of thyroid benign/malign lesions and NIFTP.
    Tastekin E; Keskin E; Can N; Canberk S; Mut A; Erdogan E; Asa N; Güldiken S; Sezer A; Azatcam M
    Pol J Pathol; 2019; 70(4):286-294. PubMed ID: 32146798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential expression of S100C in thyroid lesions.
    Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
    Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retinoblastoma expression in thyroid neoplasms.
    Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
    Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' disease.
    Erkiliç S; Koçer NE
    Endocr Pathol; 2005; 16(1):63-6. PubMed ID: 16000848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.
    Fonseca E; Nesland JM; Höie J; Sobrinho-Simões M
    Virchows Arch; 1997 Mar; 430(3):239-45. PubMed ID: 9099982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytomorphological Analysis of Thyroid Nodules Diagnosed as Follicular Variant of Papillary Thyroid Carcinoma: a Fine Needle Aspiration Study of Diagnostic Clues in 42 Cases and the Impact of Using Bethesda System in Reporting-an Institutional Experience.
    Trabzonlu L; Paksoy N
    Endocr Pathol; 2018 Dec; 29(4):351-356. PubMed ID: 30315491
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features.
    Fu G; Polyakova O; MacMillan C; Ralhan R; Walfish PG
    EBioMedicine; 2017 Apr; 18():50-55. PubMed ID: 28363612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinicopathologic characteristics of thyroid-like follicular carcinoma of the kidney: an analysis of five cases and review of literature].
    Chen X; Dou FX; Cheng XB; Guo AT; Shi HY
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):687-691. PubMed ID: 27760609
    [No Abstract]   [Full Text] [Related]  

  • 57. Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Chandler JB; Colunga M; Prasad ML; Callender GG; Quinn C; Chhieng D; Adeniran AJ
    Cancer Cytopathol; 2017 Nov; 125(11):865-875. PubMed ID: 28834409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The immunohistochemical localization of S100 in the diagnosis of papillary carcinoma of the thyroid.
    McLaren KM; Cossar DW
    Hum Pathol; 1996 Jul; 27(7):633-6. PubMed ID: 8698304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Can CD10 be used as a diagnostic marker in thyroid pathology?
    Yegen G; Demir MA; Ertan Y; Nalbant OA; Tunçyürek M
    Virchows Arch; 2009 Jan; 454(1):101-5. PubMed ID: 19031085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
    Schröder S; Wodzynski A; Padberg B
    Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.